JiangXi Tianxin Pharmaceutical Co., Ltd. (SHA:603235)
China flag China · Delayed Price · Currency is CNY
24.70
-0.46 (-1.83%)
At close: Sep 14, 2026

SHA:603235 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
554.89591.58651.22475.85622.12743.89
Depreciation & Amortization
216.92189.58154.16138.75127.11110.13
Other Amortization
2.832.831.391.392.045.95
Loss (Gain) From Sale of Assets
0.510.51-0--3.33
Asset Writedown & Restructuring Costs
-7.641.91.6812.450.94.89
Loss (Gain) From Sale of Investments
-9.06-8.93-7.68-2.07-6.632.28
Provision & Write-off of Bad Debts
2.110.273.22-3.16-3.237.03
Other Operating Activities
42.1227.51-42.04-25.67-56.4532.65
Change in Accounts Receivable
-176.77-194.39-239.117.1563.92-167.58
Change in Inventory
11.73-3.36-117.2-20.51-68.39-75.7
Change in Accounts Payable
134.6824.62128.4982.92-51.362.92
Change in Other Net Operating Assets
-91.854.97-32.4284.63-26.34107.86
Operating Cash Flow
670.94629.36499.66729.21606.61818.63
Operating Cash Flow Growth
3.80%25.96%-31.48%20.21%-25.90%-29.65%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-401.29-580.68-1,067-535.6-260.5-215.5
Sale of Property, Plant & Equipment
0.560.570.27--7.17
Investment in Securities
157.61479.11-479.44230-230.5-
Other Investing Activities
-106.2811.515.462.4535.66-31.21
Investing Cash Flow
-349.41-89.5-1,541-303.15-455.34-239.54

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-276.39312.4310090300
Long-Term Debt Repaid
--11.16-272.42-3.17-433.71-307.49
Lease Payments
-1.81-3.52-3.42-3.17-3.71-2.49
Net Debt Issued (Repaid)
144.58265.2340.0196.83-343.71-7.49
Issuance of Common Stock
----1,540-
Repurchase of Common Stock
---60.01---
Common Dividends Paid
-71.98-304.82-220.19-312.42-6.83-878.47
Other Financing Activities
14.33----26.6-
Financing Cash Flow
86.93-39.59-240.19-215.591,162-885.96

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-49.3-8.9751.7127.7763.37-19.98
Net Cash Flow
359.16491.31-1,230238.241,377-326.86

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
269.6548.68-567.3193.61346.11603.13
Free Cash Flow Growth
----44.06%-42.61%-29.92%
Free Cash Flow Margin
10.65%2.08%-25.69%10.29%15.02%23.91%
Free Cash Flow Per Share
0.610.11-1.300.440.841.53
Levered Free Cash Flow
334.59-2.78-715.82-28.07176.18-619.31
Unlevered Free Cash Flow
334.59-2.48-714.27-26.76180.51-611.39
Free Cash Flow After Leases
267.8445.16-570.72190.44342.4600.64

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
96.37145.82130.855.13125.68114.88
Change in Working Capital
-131.74-175.88-262.28131.67-79.24-91.53